Literature DB >> 3823748

Balanced physiological saline in the treatment of chronic rhinitis.

J Nuutinen, E Holopainen, T Haahtela, P Ruoppi, M Silvasti.   

Abstract

The effects of a special balanced physiological saline on nasal symptoms of 93 patients with chronic rhinitis were studied. The main diagnoses of the patients were allergic rhinitis, atrophic rhinitis and ozaena, rhinitis sicca, chronic sinusitis, nasal polyposis and postoperative condition after nasal surgery. The tested solution was administered by a simple metered dose pump. 85 (91%) of the patients reported beneficial effects of the tested solution on nasal symptoms. In addition, 22 (71%) of those patients who used continuous anti-allergic medication, mainly intranasal steroids, reported that the tested solution improved the efficacy of their ordinary drug. So the tested solution proved to be beneficial in humidifying atrophic or otherwise dry mucosa, douching crusty nose and as adjuvant therapy in the treatment of allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3823748

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

Review 1.  Treating allergic rhinitis in pregnancy.

Authors:  Vincent Piette; Jean-Pierre Daures; Pascal Demoly
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.806

2.  Comparing the efficacy of alkaline nasal douches versus decongestant nasal drops in postoperative care after septal surgery: a randomised single blinded clinical pilot study.

Authors:  Vinod Prabhu; Anita Pandey; Duncan Ingrams
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-06

Review 3.  Saline nasal irrigation: Its role as an adjunct treatment.

Authors:  Blake Papsin; Alison McTavish
Journal:  Can Fam Physician       Date:  2003-02       Impact factor: 3.275

Review 4.  Treatment of allergic rhinitis during pregnancy.

Authors:  Pascal Demoly; Vincent Piette; Jean-Pierre Daures
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.